Kangmei Pharmaceutical Co.,Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Kangmei Pharmaceutical Co.,Ltd.. Fundamentals are ordered by how Kangmei Pharmaceutical Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Cash from issuing bonds3,381,000,0000.05687622015-06-30historic
Other current liabilities2,000,000,0000.03364902015-06-30historic
Interest receivable39,529,5896.6E-41362015-06-30historic
Net cash and cash equivalents ending balance11,874,571,6810.199731522015-06-30historic
Operating profit1,699,587,1230.028591622015-06-30historic
Net income1,432,382,3120.024091682015-06-30historic
Total profit1,706,799,2600.028711762015-06-30historic
Investment income from associate and joint venture39,577,8106.7E-41812015-06-30historic
Total comprehensive income1,449,607,0650.024381902015-06-30historic
Net change in cash1,904,681,7410.032042282015-06-30historic
Interests payable127,692,2030.002152322015-06-30historic
Inventories8,535,359,9980.143562762015-06-30historic
Cash paid for dividends, profits or interests919,809,0960.015472962015-06-30historic
Goodwill304,734,7100.005133402015-06-30historic
Net cashflow from financing activities2,027,648,9560.03413542015-06-30historic
Cash paid for taxes797,071,7860.013414072015-06-30historic
Financial expenses198,597,4550.003344252015-06-30historic
Prepayment794,692,2830.013374622015-06-30historic
Long term equity investment378,133,0500.006364952015-06-30historic
Short term borrowings3,218,353,2330.054135052015-06-30historic
Cash outflows from operating activities9,436,378,9360.158725092015-06-30historic
Revenue9,065,136,9840.152485162015-06-30historic
Proceeds from sell of investment17,990,0003.0E-45242015-06-30historic
Cash inflows from operating activities9,675,216,8340.162745252015-06-30historic
Total liabilities14,653,799,4780.246485502015-06-30historic
Net cash flows from investing activities-361,805,113-0.006095542015-06-30historic
Cash inflows from financing activities4,796,000,0000.080675542015-06-30historic
Notes receivable325,936,1410.005485662015-06-30historic
Total cost of goods sold7,405,150,7450.124555822015-06-30historic
Total liabilities and equity32,120,274,6010.540265892015-06-30historic
Intangible assets1,066,592,8360.017945912015-06-30historic
Other current assets246,064,8790.004146332015-06-30historic
Other payables481,309,3740.00816662015-06-30historic
Fixed assets4,303,938,8020.072396862015-06-30historic
Comprehensive income attributable to minority shareholders-518,270-1.0E-56952015-06-30historic
Minority interests gain-518,270-1.0E-57082015-06-30historic
Selling expenses242,396,9260.004087182015-06-30historic
Long term borrowings5,033,1108.0E-57212015-06-30historic
Accounts payable1,531,963,0100.025777532015-06-30historic
Non-operating loss2,857,1425.0E-58042015-06-30historic
Purchases of fixed assets and others258,839,9830.004358112015-06-30historic
Total non-current assets7,596,118,7210.127778442015-06-30historic
Deferred tax assets72,136,8320.001218642015-06-30historic
Capital reserve3,657,275,4870.061528642015-06-30historic
Disposal of fixed assets and others132,6270.09562015-06-30historic
Diluted eps00.09782015-06-30historic
Minority interest21,473,1843.6E-49882015-06-30historic
Other receivables72,909,8740.0012310472015-06-30historic
Payroll payable30,795,9655.2E-411192015-06-30historic